An Update of Acyl-CoA: Cholesterol Acyltransferase Inhibition in Animal and Human In Vitro and In Vivo Models of Atherosclerosis
Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents · 2001
DOI: 10.2174/1568013013359113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents, 2001. Verfasst von J. wu und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
wu, J., Doshi, R., & Rodriguez, A. (2001). An Update of Acyl-CoA: Cholesterol Acyltransferase Inhibition in Animal and Human In Vitro and In Vivo Models of Atherosclerosis. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. https://doi.org/10.2174/1568013013359113
Vancouver
wu J, Doshi R, Rodriguez A. An Update of Acyl-CoA: Cholesterol Acyltransferase Inhibition in Animal and Human In Vitro and In Vivo Models of Atherosclerosis. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. 2001. doi:10.2174/1568013013359113
BibTeX
@article{wu2001,
author = {wu, J. and Doshi, R. and Rodriguez, A.},
title = {An Update of Acyl-CoA: Cholesterol Acyltransferase Inhibition in Animal and Human In Vitro and In Vivo Models of Atherosclerosis},
journal = {Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents},
year = {2001},
doi = {10.2174/1568013013359113}
}
EUVIMED